University of Queensland

What University of Queensland does

The University of Queensland is a public research-intensive university established in 1909 under the University of Queensland Act 1998, headquartered at its St Lucia campus in Brisbane with additional campuses at Gatton (agriculture and veterinary science) and Herston (health sciences). It employs approximately 8,000 staff across academic, research, and professional roles and is ranked #40 globally in the QS World University Rankings 2027, with 17 subjects in the global top 50 and a #37 global position in the Performance Ranking of Scientific Papers. The university serves domestic and international students from more than 140 countries through undergraduate, postgraduate coursework, and research degree programs, and generates research revenue through commissioned R&D, government grants (NHMRC, ARC, MRFF, ARENA, CARB-X), and international development partnerships (e.g., Gates Foundation-funded Ethiopia-UQ Alliance).

UQ's research is organized across specialized institutes including the Australian Institute for Bioengineering and Nanotechnology (AIBN), Institute for Molecular Bioscience, Queensland Brain Institute, Sustainable Minerals Institute (SMI), and the Australian Centre for Advanced Photovoltaics (ACAP). Proprietary technology platforms developed at UQ include the Molecular Clamp protein-stabilization technology (licensed to Sanofi in a ~US$1.6B transaction), the Vicebio respiratory virus vaccine platform (acquired by Yorkville for US$1.15B), graphene-based battery work with Graphene Manufacturing Group, perovskite solar cells with Halocell Energy, precision fermentation with All G, scorpion venom-derived pain therapy with PreveCeutical Medical, and radionuclide cancer therapy with AdvanCell. SMI operates an industry consortium including BHP, Rio Tinto, Vale, Newmont, and Codelco.

The university's business model spans four revenue streams: research and development services (grants and contract research), technology licensing and commercialization (administered by wholly-owned subsidiary UniQuest, which manages 240+ active licensing agreements and equity in 135+ spin-off companies, with cumulative global product sales from UQ-derived products exceeding $88.5 billion), education and training services (international tuition at AUD $38,000–$56,000 per year plus Commonwealth-supported domestic places and research training scholarships), and spin-off equity returns. Commercialization and go-to-market activities are executed through UniQuest and UQ Ventures (including the ilab Accelerator and FaBA Food and Beverage Accelerator).

Name

University of Queensland

Legal name

The University of Queensland

Website

https://uq.edu.au

Company type

Private

Founded year

1909

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

The University of Queensland is a public research-intensive university in Brisbane, Australia, founded 1909, serving 55,000+ domestic and international students and operating specialized research institutes across biotechnology, sustainable minerals, brain science, and renewable energy, with commercialization via wholly-owned UniQuest managing 240+ licenses and 135+ spin-offs.

Ownership category

akta.pro rank

Product category

Higher Education and Research

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (61131), Colleges, Universities, and Professional Schools (611310), Scientific Research and Development Services (5417)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Public Research Universities with Comprehensive Graduate & Professional Schools (EDAHAAAF)

Keywords

• Higher education services
• Research commercialization
• Technology licensing
• Industry research partnerships
• Academic degree programs

Headquarters

HQ city

Saint Lucia

HQ country

Australia

HQ region

Oceania

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Research and Development Services: UQ conducts commissioned and grant-funded research for government agencies, industry partners, and international bodies. This includes research contracts, collaborative R&D agreements, and grant funding from bodies such as the Gates Foundation, National Health and Medical Research Council (NHMRC), and the Australian Research Council (ARC).
2. Technology Licensing and Commercialization: Through UniQuest, UQ commercializes research outcomes via licensing agreements, equity stakes in spin-off companies, and milestone payments. Notable outcomes include the Molecular Clamp technology licensed to Sanofi (~$1.6B total value) and the sale of Vicebio to Yorkville for US$1.15B. Cumulative global product sales from UQ-derived products exceed $88.5 billion.
3. Education and Training Services: UQ generates revenue through domestic and international student tuition across undergraduate, postgraduate, and research degree programs. Revenue is also derived from executive education, professional development programs, and continuing education offerings.
4. Spin-off Company Equity: UQ holds equity positions in spin-off companies formed from its research. Over 135 companies have been launched from UQ research, with 240+ active licensing agreements generating ongoing returns to the university.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

The University of Queensland is a public research-intensive university that delivers undergraduate, postgraduate, and doctoral degree programs to domestic and international students across multiple disciplines. It conducts commissioned and grant-funded research for government and industry partners through specialized institutes (AIBN, IMB, QBI, SMI), and commercializes resulting intellectual property through its wholly-owned subsidiary UniQuest via licensing agreements, milestone payments, and spin-off equity stakes.

Product overview

The University of Queensland is a leading research-intensive university offering comprehensive academic degree programs across undergraduate, postgraduate, and doctoral levels. The institution operates multiple specialized research institutes including the Australian Institute for Bioengineering and Nanotechnology (AIBN), Institute for Molecular Bioscience, Queensland Brain Institute, and Sustainable Minerals Institute. UQ's innovation ecosystem supports technology transfer and commercialization through UniQuest, UQ Ventures, and the ilab Accelerator program. The university's research portfolio spans advanced manufacturing, biotechnology, renewable energy, agricultural science, and healthcare innovation, with a strong focus on translating discoveries into real-world applications through industry partnerships and startup support.

Differentiator

Problem solved

Functional benefit

Products and services

• UQ Academic Degree Programs

Quantifiable outcome

• Cumulative global product sales from UQ-derived products exceed $88.5 billion
• +6 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

23 partnerships are on record, tiered core and minor.

• Ethiopian Institute of Agricultural Research (EIAR)coreStrategic or Co-development PartnerThe Ethiopia-UQ Alliance is a flagship international development research partnership addressing agricultural challenges in Ethiopia. Funded in part by the Bill & Melinda Gates Foundation, the partnership focuses on improving crop yields, livestock productivity, and food security through collaborative research between EIAR researchers and UQ academics.
• Griffith UniversitycoreStrategic or Co-development PartnerUQ and Griffith University collaborate on prostate cancer research, leveraging complementary expertise from both institutions' medical research schools. The partnership involves joint research programs, shared facilities, and collaborative grant applications in oncology and translational medicine.
• Australian Centre for Advanced Photovoltaics (ACAP)coreStrategic or Co-development PartnerUQ is a core consortium partner in ACAP, Australia's national research hub for advanced photovoltaic and solar cell technologies. Led by UNSW Sydney, ACAP brings together Australian universities and research institutions to develop next-generation solar cells including perovskite and tandem photovoltaic devices.
• Monell Chemical Senses CenterminorStrategic or Co-development PartnerUQ partners with the Monell Chemical Senses Center (Philadelphia, USA), the world's only independent research institute dedicated to taste and smell science. Collaborations focus on chemosensory research, food science, and human health implications of chemical senses.
• National Institutes of Health (NIH)coreStrategic or Co-development PartnerUQ maintains active research collaborations with various institutes within the NIH (USA), particularly in biomedical and health research areas. These partnerships involve joint research projects, data sharing, and exchange of scientific expertise in fields including infectious disease, cancer, and neuroscience.
• University of BristolminorStrategic or Co-development PartnerUQ has academic research partnerships with the University of Bristol (UK) spanning multiple disciplines. Collaborations include joint research projects, PhD student exchanges, and collaborative grant applications in areas of mutual research strength.
• QIMR Berghofer Medical Research InstitutecoreStrategic or Co-development PartnerUQ maintains a close research partnership with QIMR Berghofer in Brisbane, one of Australia's leading medical research institutes. Collaborations span immunology, infectious disease, cancer research, and mental health, with shared resources, joint appointments, and collaborative projects.
• Indian Institute of Technology Delhi (IIT Delhi)coreStrategic or Co-development PartnerUQ and IIT Delhi have a joint PhD partnership that enables doctoral students to undertake research with supervisors from both institutions. This program builds research capacity and fosters collaboration between two of the Asia-Pacific's leading research universities.
• Lady Shri Ram College for WomenminorStrategic or Co-development PartnerUQ has established academic partnerships with Lady Shri Ram College for Women (New Delhi, India), one of India's premier women's colleges affiliated with the University of Delhi. Collaborations may include student exchange, joint research, and faculty engagement.
• SRM Institute of Science and TechnologyminorStrategic or Co-development PartnerUQ has academic partnerships with SRM Institute (Chennai, India), facilitating joint research initiatives, student exchanges, and collaborative programs between the institutions across science and technology disciplines.
• Vellore Institute of Technology (VIT)minorStrategic or Co-development PartnerUQ maintains academic partnerships with VIT (Vellore, India), enabling joint research collaborations, student exchange programs, and academic engagement between the institutions.
• MSF SugarminorStrategic or Co-development PartnerUQ conducts research on rare sugars and sugar-derived compounds in partnership with MSF Sugar, exploring applications in health, nutrition, and functional foods. The partnership leverages UQ's agricultural research capabilities and MSF Sugar's sugar production infrastructure.
• Graphene Manufacturing GroupcoreStrategic or Co-development PartnerUQ researchers collaborate with Graphene Manufacturing Group (GMG) on the development and commercialization of graphene-based battery and energy storage technologies. Research focuses on improving battery performance for electric vehicles and grid-scale energy storage applications.
• Rio TintocoreStrategic or Co-development PartnerRio Tinto is a key industry partner in UQ's battery research and Sustainable Minerals Institute activities. The partnership covers research into battery technology R&D, sustainable mining practices, and minerals processing, reflecting Rio Tinto's interests in the energy transition.
• UniQuestcoreOEM/ Whitelabel/ Licensing PartnerUniQuest is UQ's dedicated technology transfer and commercialization company. It identifies, protects, and commercializes research outputs from UQ researchers, managing over 240 active licensing agreements, equity in spin-off companies, and major licensing deals including the Sanofi Molecular Clamp transaction.
• Halocell EnergyminorStrategic or Co-development PartnerUQ partners with Halocell Energy on perovskite solar cell technology, contributing research expertise to advance the commercialization of high-efficiency, low-cost solar panels for residential and commercial applications.
• PreveCeutical MedicalminorStrategic or Co-development PartnerUQ and PreveCeutical Medical collaborate on pain therapy research, including the development of a novel pain management product (HemoHim) derived from scorpion venom compounds. The partnership focuses on non-opioid pain therapies with reduced side effects.
• All GminorStrategic or Co-development PartnerUQ partners with All G in the field of precision fermentation, developing technologies for the production of alternative proteins and bio-manufactured products through microbial fermentation platforms, targeting food security and sustainable protein production.
• AdvanCellminorStrategic or Co-development PartnerUQ collaborates with AdvanCell, an Australian radiopharmaceutical company, on the development of targeted cancer treatments using radionuclide therapies. Research leverages UQ's expertise in radiochemistry, medicinal chemistry, and cancer biology.
• Mater ResearchcoreStrategic or Co-development PartnerUQ maintains a formal research partnership with Mater Research (Mater Misericordiae Ltd), one of Queensland's leading hospital and research organizations. The partnership covers translational medical research, clinical trials, and shared research facilities at the Mater-Queensland Centre for Women's Infectious Diseases and other joint research units.
• Sustainable Minerals Institute (SMI) Industry ConsortiumcoreStrategic or Co-development PartnerUQ's SMI operates an industry consortium with major global mining companies including BHP, Rio Tinto, Newmont, Vale, and Codelco. Members fund directed research, access exclusive research outputs, and participate in training programs and workshops on mining sustainability, water management, and energy transition in mining.
• CIMMYT (International Maize and Wheat Improvement Center)coreStrategic or Co-development PartnerUQ partners with CIMMYT, the Mexico-based international agricultural research organization, on crop science, wheat and maize improvement programs, and global food security research. CIMMYT is part of the CGIAR system and represents a key partner in UQ's international agricultural research portfolio.
• ICRISAT (International Crops Research Institute for the Semi-Arid Tropics)coreStrategic or Co-development PartnerUQ collaborates with ICRISAT on research addressing agricultural challenges in semi-arid tropical regions, including crop improvement, dryland agriculture, and climate resilience. ICRISAT is a key partner in UQ's international agricultural research programs and Ethiopia-UQ Alliance activities.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Regional players

• CSIRO (Commonwealth Scientific and Industrial Research Organisation): Australia's national science agency with overlapping research domains (biotech, energy, mining, agriculture) and a significant commercialization program. Comparable as a publicly-funded R&D engine and technology transfer entity operating in the same Australian ecosystem, but distinct mission as a research agency versus a teaching university.

Broad incumbents

• ETH Zurich: Top-10 global research-intensive university with strong STEM focus, active spin-off ecosystem, and deep industry partnerships in pharma and engineering. Comparable to UQ as a research powerhouse driving IP commercialization, though primarily engineering/science focused rather than comprehensive.
• National University of Singapore (NUS): Asia-leading research university with significant commercialization infrastructure, strong IP licensing pipeline, and global ranking presence. Comparable to UQ in multidisciplinary research and Asia-Pacific student recruitment, though larger and better-funded at the system level.

Others

• UNSW Sydney:

Direct peers

• University of Sydney: Another leading Group of Eight research university with strong commercialization track record, broad disciplinary research, and significant international student enrollment. Competes head-to-head with UQ for global rankings, top PhD students, and industry research partnerships.
• University of Melbourne: Australia's top-ranked Group of Eight research university with comparable scale, multi-campus structure, and significant research commercialization output (including its own technology transfer office). Directly competes with UQ for international students, faculty, and research grants across the Asia-Pacific region.
• University of Western Australia: Group of Eight research university with comparable mining and resources research, and similar international student mix. Competes for industry research funding in resources and agriculture, and for Western Pacific student markets.
• Monash University: Large Group of Eight research university with global multi-campus footprint, strong pharmaceutical and engineering research, and an active commercialization arm (Monash Innovation). Direct peer in biotech, materials science, and clinical translation research.
• University of Adelaide: Group of Eight peer with strength in mining, agriculture, and wine science. Direct peer for resources-sector consortium-style research and for international student recruitment, though smaller in scale than UQ.
• Australian National University (ANU): Federally-funded research-intensive university with similar interdisciplinary research breadth and strong international positioning. Competes with UQ for government research funding, top researchers, and global ranking positions in the Asia-Pacific.

Market position

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/school/university-of-queensland
• Xx.com/uq_news
• Facebookfacebook.com/uniofqld

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds8 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Queensland